Home LiteratureArticle Details
PMID: 21308681 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33.

European journal of immunology ·Vol. 41 ·No. 3 ·2011-03-00 ·Pages 760-72

Andrade MV, Iwaki S, Ropert C, Gazzinelli RT, Cunha-Melo JR, Beaven MA

Abstract

IL-33 is associated with atopic and autoimmune diseases and, as reported here, it interacts synergistically with Ag to markedly enhance production of inflammatory cytokines in rodent mast cells even in the absence of degranulation. Investigation of the underlying mechanisms revealed that synergy in signaling occurred at the level of TGF-β-activated kinase 1, which was then transmitted downstream through JNK, p38 MAP kinase, and AP-1. Stimulation of the Ca(2+) /calcineurin/NFAT pathway by Ag, which IL-33 did not, was critical for the synergy between Ag and IL-33. For example, selective stimulation of the NFAT pathway by thapsigargin also markedly enhanced responses to IL-33 in a calcineurin-dependent manner. As indicated by luciferase-reporter assays, IL-33 failed to stimulate the transcriptional activities of NFAT and AP-1 but augmented the activation of these transcription factors by Ag or thapsigargin. Robust stimulation of NF-κB transcriptional activity by IL-33 was also essential for the synergy. These and pharmacologic data suggested that the enhanced production of cytokines resulted in part from amplification of the activation of AP-1 and NFAT as well as co-operative interactions among transcription factors. IL-33 may retune mast cell responses to Ag toward enhanced cytokine production and thus determine the symptoms and severity of Ag-dependent allergic and autoimmune diseases.

MeSH Terms
Animals Antigens/administration & dosage Calcineurin/metabolism Calcium/metabolism Cell Line Cytokines/biosynthesis,genetics In Vitro Techniques Interleukin-33 Interleukins/administration & dosage Mast Cells/immunology,metabolism Mice Mice, Inbred C57BL Mice, Knockout Models, Immunological Myeloid Differentiation Factor 88/deficiency,genetics,immunology NFATC Transcription Factors/metabolism Rats Recombinant Proteins/administration & dosage Signal Transduction/immunology Transcription Factor AP-1/metabolism Transcription, Genetic
Chemicals
Antigens Cytokines Il33 protein, mouse Interleukin-33 Interleukins Myd88 protein, mouse Myeloid Differentiation Factor 88 NFATC Transcription Factors Recombinant Proteins Transcription Factor AP-1 Calcineurin Calcium
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Andrade Marcus V
Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1760, USA.
Iwaki Shoko
Ropert Catherine
Gazzinelli Ricardo T
Cunha-Melo Jose R
Beaven Michael A
References (56)
56 references, click to expand
  1. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
    Cytokine. 2008 Jun;42(3):358-64 PMID: 18450470
  2. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
    Int Immunol. 2008 Aug;20(8):1019-30 PMID: 18550585
  3. G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.
    Immunol Lett. 2007 Nov 15;113(2):59-69 PMID: 17919738
  4. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.
    Mol Cell Biol. 2002 Oct;22(20):7158-67 PMID: 12242293
  5. IL-33 exacerbates antigen-induced arthritis by activating mast cells.
    Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10913-8 PMID: 18667700
  6. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.
    Blood. 2009 Feb 12;113(7):1526-34 PMID: 18955562
  7. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Nature. 1999 Mar 18;398(6724):252-6 PMID: 10094049
  8. New aspects of cyclosporin a mode of action: from gene silencing to gene up-regulation.
    Mini Rev Med Chem. 2003 May;3(3):205-14 PMID: 12570836
  9. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation.
    J Exp Med. 2006 Feb 20;203(2):337-47 PMID: 16432253
  10. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
    J Immunol. 2007 Aug 15;179(4):2551-5 PMID: 17675517
  11. Mulan: multiple-sequence alignment to predict functional elements in genomic sequences.
    Methods Mol Biol. 2007;395:237-54 PMID: 17993678
  12. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway.
    J Leukoc Biol. 2009 Oct;86(4):769-78 PMID: 19451398
  13. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
    Genes Dev. 2005 Nov 15;19(22):2668-81 PMID: 16260493
  14. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells.
    Blood. 2006 Jan 15;107(2):610-8 PMID: 16174756
  15. IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation.
    Inflamm Res. 2010 Mar;59(3):207-18 PMID: 19763788
  16. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun.
    EMBO J. 2000 Sep 1;19(17):4783-95 PMID: 10970869
  17. Mast cells as "tunable" effector and immunoregulatory cells: recent advances.
    Annu Rev Immunol. 2005;23:749-86 PMID: 15771585
  18. IL-1, IL-18, and IL-33 families of cytokines.
    Immunol Rev. 2008 Jun;223:20-38 PMID: 18613828
  19. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.
    J Immunol. 2007 Aug 15;179(4):2051-4 PMID: 17675461
  20. Regulation of Ca2+ signaling with particular focus on mast cells.
    Crit Rev Immunol. 2009;29(2):155-86 PMID: 19496745
  21. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
    J Immunol. 2002 May 1;168(9):4737-46 PMID: 11971024
  22. IL-33 can promote survival, adhesion and cytokine production in human mast cells.
    Lab Invest. 2007 Oct;87(10):971-8 PMID: 17700564
  23. Molecular regulation of mast cell activation.
    J Allergy Clin Immunol. 2006 Jun;117(6):1214-25; quiz 1226 PMID: 16750977
  24. rVISTA 2.0: evolutionary analysis of transcription factor binding sites.
    Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W217-21 PMID: 15215384
  25. IL-33 exacerbates autoantibody-induced arthritis.
    J Immunol. 2010 Mar 1;184(5):2620-6 PMID: 20139274
  26. Partners in transcription: NFAT and AP-1.
    Oncogene. 2001 Apr 30;20(19):2476-89 PMID: 11402342
  27. Essential function for the kinase TAK1 in innate and adaptive immune responses.
    Nat Immunol. 2005 Nov;6(11):1087-95 PMID: 16186825
  28. Disease-associated functions of IL-33: the new kid in the IL-1 family.
    Nat Rev Immunol. 2010 Feb;10(2):103-10 PMID: 20081870
  29. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Mol Cell. 2004 May 7;14(3):289-301 PMID: 15125833
  30. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells.
    Blood. 2004 Oct 15;104(8):2410-7 PMID: 15217825
  31. New developments in mast cell biology.
    Nat Immunol. 2008 Nov;9(11):1215-23 PMID: 18936782
  32. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
    Cytokine. 2007 Dec;40(3):216-25 PMID: 18023358
  33. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.
    J Rheumatol. 2010 Jan;37(1):18-25 PMID: 19918048
  34. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.
    J Immunol. 2008 Nov 1;181(9):5981-9 PMID: 18941187
  35. Thapsigargin-induced secretion is dependent on activation of a cholera toxin-sensitive and phosphatidylinositol-3-kinase-regulated phospholipase D in a mast cell line.
    J Pharmacol Exp Ther. 1998 Apr;285(1):110-8 PMID: 9536000
  36. IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma.
    Clin Exp Allergy. 2010 Feb;40(2):200-8 PMID: 19906013
  37. Regulation of the mast cell response to the type 1 Fc epsilon receptor.
    Immunol Rev. 2007 Jun;217:231-54 PMID: 17498063
  38. The IL-33/ST2 pathway: therapeutic target and novel biomarker.
    Nat Rev Drug Discov. 2008 Oct;7(10):827-40 PMID: 18827826
  39. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
    J Biol Chem. 2003 May 16;278(20):18485-90 PMID: 12624112
  40. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
    Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):282-7 PMID: 17185418
  41. Integrated signalling pathways for mast-cell activation.
    Nat Rev Immunol. 2006 Mar;6(3):218-30 PMID: 16470226
  42. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors.
    J Immunol. 1998 Nov 1;161(9):4866-74 PMID: 9794420
  43. IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
    PLoS One. 2010 Aug 03;5(8):e11944 PMID: 20689814
  44. The cytokine interleukin-33 mediates anaphylactic shock.
    Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9773-8 PMID: 19506243
  45. Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells.
    J Biol Chem. 1993 Jan 25;268(3):1749-56 PMID: 8420951
  46. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.
    Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18660-5 PMID: 18003919
  47. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit.
    J Biol Chem. 2005 Dec 2;280(48):40261-70 PMID: 16176929
  48. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling.
    Nat Immunol. 2002 Aug;3(8):780-6 PMID: 12118249
  49. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
    J Leukoc Biol. 2007 Dec;82(6):1481-90 PMID: 17881510
  50. IL-33: a sheep in wolf's clothing?
    Sci STKE. 2007 Jun 12;2007(390):pe31 PMID: 17565120
  51. Our perception of the mast cell from Paul Ehrlich to now.
    Eur J Immunol. 2009 Jan;39(1):11-25 PMID: 19130582
  52. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.
    Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4448-53 PMID: 20160089
  53. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
    Immunity. 2005 Nov;23(5):479-90 PMID: 16286016
  54. Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7722-6 PMID: 8052650
  55. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    J Mol Biol. 2004 Jun 18;339(5):1059-75 PMID: 15178248
  56. Shared principles in NF-kappaB signaling.
    Cell. 2008 Feb 8;132(3):344-62 PMID: 18267068
Article Info
Journal
European journal of immunology
Abbr.
Eur J Immunol
ISSN
1521-4141
Published
2011-03-00
Epub
2011-00-10
Pages
760-72
Language
English
Region
Germany
NLM ID
1273201
PMCID
PMC3085255
Subset
IM
Grants
FIC NIH HHS · R01 TW006612-04 · United States
FIC NIH HHS · R01 TW006612-01 · United States
FIC NIH HHS · R01 TW006612 · United States
FIC NIH HHS · R01 TW006612-03 · United States
Intramural NIH HHS · United States
FIC NIH HHS · R01 TW006612-05 · United States
FIC NIH HHS · R01 TW006612-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com